Overpriced technology in radiation oncology

References 

1. Doyle R. Health care costs. Sci Am. 1999;280(4):36
   • CrossRef
2. Smith S, Freeland M, Heffler S, et al.  The next ten years of health spending. Health Affairs. 1998;17:128–140
3. Shipley WU, Verhey LJ, Munzenrider JE, et al.  Advanced prostate cancer (The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional high dose irradiation using photons alone). Int J Radiat Oncol Biol Phys. 1995;32:3–12
   • Abstract
   • Full-Text PDF (1088 KB)
   • CrossRef
4. Shipley WU, Tepper JE, Prout GA, et al.  Proton radiation as boost therapy for localized prostate carcinoma. JAMA. 1979;241:1912–1915
   • MEDLINE
5. Castellucci L. Proton therapy faces high hurdles to general use. J Natl Cancer Inst. 1998;90:1768–1769
   • MEDLINE
   • CrossRef
6. Suit HD. Local control and patient survival. Int J Radiat Oncol Biol Phys. 1992;23:653–660
   • Abstract
   • Full-Text PDF (1223 KB)
   • CrossRef
7. Tannock IF. Conventional cancer therapy (Promise broken or promise delayed?). Lancet. 1998;251(Suppl. 2):SII9–SII916
8. Marks LB, Halperin EC. Radiosurgery is not “standard of care” for solitary brain metastases. Int J Radiat Oncol Biol Phys. 1994;28:797–802
   • Abstract
   • Full-Text PDF (694 KB)
   • CrossRef
9. Mitchell P. American Society of Clinical Oncology publishes meeting results early. Lancet. 1999;353:1418
   • Full Text
   • Full-Text PDF (56 KB)
   • CrossRef
10. Shakespeare W. Julius Caesar. Act I, Scene I.
11. Kelly W. We have met the enemy and he is us. Seattle: Fontagraphics Books; 1994;